BNTX
$98.76
Revenue | $1190Mn |
Net Profits | $259.5Mn |
Net Profit Margins | 21.81% |
Biontech Se’s revenue fell -19.54% since last year same period to $1190Mn in the Q4 2024. On a quarterly growth basis, Biontech Se has generated -3.11% fall in its revenue since last 3-months.
Biontech Se’s net profit fell -43.33% since last year same period to $259.5Mn in the Q4 2024. On a quarterly growth basis, Biontech Se has generated 32.77% jump in its net profits since last 3-months.
Biontech Se’s net profit margin fell -29.57% since last year same period to 21.81% in the Q4 2024. On a quarterly growth basis, Biontech Se has generated 37.03% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.37 |
EPS Estimate Current Year | 0.37 |
Biontech Se’s earning per share (EPS) estimates for the current quarter stand at 0.37 - a 121.99% jump from last quarter’s estimates.
Biontech Se’s earning per share (EPS) estimates for the current year stand at 0.37.
Earning Per Share (EPS) | 1.08 |
Biontech Se’s earning per share (EPS) fell -43.16% since last year same period to 1.08 in the Q4 2024. This indicates that the Biontech Se has generated -43.16% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-09-30 | -1.7 | 0.88 | 151.76% |
2024-03-31 | -1.17 | -1.41 | -20.51% |
2024-06-30 | -2.02 | -3.36 | -66.34% |
2025-03-10 | 0.37 | 1.08 | 188.85% |